UroGen Pharma Ltd.·4

Dec 1, 4:46 PM ET

WEN LEANA 4

4 · UroGen Pharma Ltd. · Filed Dec 1, 2025

Insider Transaction Report

Form 4
Period: 2025-11-26
WEN LEANA
Director
Transactions
  • Exercise/Conversion

    ordinary shares

    2025-11-26+2,0002,000 total
  • Exercise/Conversion

    Restricted Stock Unit

    2025-11-262,0006,000 total
    Ordinary Shares (2,000 underlying)
Footnotes (1)
  • [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4